Medrio offers solutions and support to pharmaceuticals, biotech, medical devices, and diagnostics, ensuring quality data capture and optimized workflows with CDMS/EDC, eCOA/ePRO, eConsent, and RTSM solutions.
N/A
Zelta
Score 8.0 out of 10
N/A
Zelta is a cloud-based unified clinical data management and acquisition platform with customizable modules, that can be tailored to the meet the needs of clinical trials and accelerate outcomes.
N/A
Pricing
Medrio
Zelta
Editions & Modules
No answers on this topic
No answers on this topic
Offerings
Pricing Offerings
Medrio
Zelta
Free Trial
No
No
Free/Freemium Version
No
No
Premium Consulting/Integration Services
No
No
Entry-level Setup Fee
No setup fee
Optional
Additional Details
—
Subscription - For larger organizations and those who need a predictable budget. Most modules included without incurring additional fees. Eligible for volume discounts.
Pay per use - For organizations that need flexibility without a long term contractual commitment. Transparent a la carte pricing, no minimums. Fees start when trial goes live.
It was easier to understand the usability of the software [Zelta]. For our engineers [it] was easier to migrate our data, and fully set up everything. We found out that comparing other software[s], this one is safe, easy to use, has more functionalities, [and it's] easier to …
IBM Clinical Trail offers an improvement on the above as it is considerably easier to navigate and has many more features. The side did seem faster however and could be used via an app which is useful in a busy environment. Both are around the same price bracket give or take.
Zelta is as good or better than Rave. I believe that Zelta has a more friendly user interface and is easier to navigate on the designer and Site side. CRF build and study build in general appears to be easier and Zelta can be used for almost any kind of clinical study that Rave …
I have used Clindex, Oracle Clinical, MediData, and MS Access for clinical trials. The product I had the most success with was Clindex but Zelta was a close second. I did not select Zelta as it was being used when I joined the company. I became a developer within a few months …
Zelta by Merative supersedes the Medrio EDC at any given point of time and on all evaluation criteria. Also as compared to Medidata Rave EDC, database programming is easier due to its intuitive GUI; someone with little or absolutely no knowledge of any programming language can …
Zelta by Merative supersedes the Medrio EDC at any given point of time and on all evaluation criteria. Also as compared to Medidata RAVE EDC, database programming is easier due to its intuitive GUI and someone with little or absolutely no knowledge of any programming language …
Zelta is a fast database, doesn't cause waiting during the data entry or when saving the data. This is mostly appreciated by the site staff as they have limited time and any delay is crucial for them. Zelta has an unlimited option for edit checks that helps collect accurate …
Zelta has an easier set-up, maintenance and modifiability. Also, there is a cost saving when using Zelta by Merative for a study as Medidata is very expensive.
More flexibility with Zelta, less heavy to design and offer[s] strong feature[s]. Rave is a stronger EDC system with a very interesting reporting option and a very good reputation with the users, however very heavy to manipulate from the design side.
Medrio is very user friendly and even allows the user to print out the eCRFs to be used as source documents. This makes creating source documents very easy for the Research team and the information directly matches the EDC, which makes the monitoring process go much smoother. The process for withdrawing a subject can be a bit confusing, as the system only allows for a "screen-failure" designation and not an option for withdrawal, or is lost to follow-up.
Zelta is a good tool for companies currently utilizing multiple software platforms to create and monitor clinical trial information. Due to the price, it is best suited for large pharmaceutical manufacturers with active pipelines and high R&D spend. Zelta's value is more limited to smaller, more focused companies.
The system does not allow a separate designation for screen failures that were lost to follow-up or who were withdrawn by the PI.
When a subject is deemed a screen-failure, eCRFs are still expected to be filled out and it is unclear which ones unless otherwise directed by the in-house team.
Would like to have more access to report review. Most of the functions are controlled by the initial data management setup of the specific reports. I would like to be able to run my own custom programs as a CRA (some way to bypass internal programming).
Sites note that they are limited in pulling tables (with specific information ) based on internal programming. I only see what DM has allowed with the CVS/EXCEL tables.
We are satisfied from our experience with Zelta by Merative, the close collaboration we have with the Zelta team is also something we value. We plan to use Zelta for a long time
It is easy to use, it helps us to be more productive, work better with teams anywhere they are, especially during the pandemic it was really helpful, it is easier to find data, to organize data, improving our findings, reducing time significantly, and more importantly been able to help in better ways our patients.
I have not had any technical issues with this product in the two years I've used it, which speaks for itself. I like how I am now able to use my email address to sign in instead of remembering yet another user name, this makes using this EDC a much more enjoyable experience.
Our organization has been using both Zelta and in-house applications. The main considerations on which one to use for a particular study is time to get the databases running, cost, and ease of use. For some studies, the time and cost of using Zelta are negative factors, and an in-house system is selected.
Zelta is as good or better than Rave. I believe that Zelta has a more friendly user interface and is easier to navigate on the designer and Site side. CRF build and study build in general appears to be easier and Zelta can be used for almost any kind of clinical study that Rave can be used for.